Protecting Our Planet

We seek to mitigate our impact on the environment, because the health of the planet is inherently linked to the health of those who inhabit it. We do this by focusing on:

Climate Action and Resilience. Global temperatures are increasing at an alarming rate, largely because of greenhouse gases (GHGs), which trap heat in the atmosphere. We have ambitious targets to reduce our absolute scope 1 and 2 GHG emissions—our operational emissions—by 25% by 2025 and by 46% by 2030 (vs. 2019), and to reduce our absolute scope 3 emissions—indirect emissions that occur in our value chain—by 25% by 2030 (vs. 2020). Our GHG emissions targets were validated by the Science Based Targets initiative (SBTi), demonstrating that our commitments are ambitious and support global efforts to tackle climate change.

Pharmaceuticals in the Environment.We assess and mitigate the environmental impact of pharmaceutical ingredients, including Antimicrobials, from our operations and work with our supply chain to do the same. Our sites are required to follow emission and effluent-related requirements, and we have a risk-based approach for understanding and controlling the discharge of priority active pharmaceutical ingredients (API) in wastewater from our facilities. We have also committed to work with patients and health care professionals to provide them with educational messaging to tackle one of the main sources of Antimicrobial Resistance (AMR) which results from the inappropriate use of antibiotics. 

Responsible Use of Natural Resources. We have a responsibility to conserve resources, including water and materials used in the manufacturing, packaging and delivery of our products. Our sites evaluate water conservation opportunities and those in areas projected to be in water stress have formalized water conservation programs. In 2022, we reduced our water withdrawal by 17% in areas projected to be in water stress (vs. 2020).

Effluents and Waste. We proactively prevent and address waste at various stages of our operations. We require our sites to establish and implement initiatives for minimizing hazardous and non-hazardous waste and implement reuse and recycling programs.

ESG Progress Report

Find out more

Share this article:

You might also be interested

Teva Expands Partnership to Bring Critical Medicines to Children Living with Cancer

Teva Expands Partnership to Bring Critical Medicines to Children Living with Cancer

Behind the
Numbers

“Mental health care is not a one stop deal": How Teva is Combining Medicine and Ongoing Support

“Mental health care is not a one stop deal": How Teva is Combining Medicine and Ongoing Support

Behind the
Numbers

Behind the Numbers: Working to Tackle Breast Cancer in Ghana

Behind the Numbers: Working to Tackle Breast Cancer in Ghana

ESG at Teva

Making Connections for the Health of People and Our World: Teva's 2021 ESG Progress Report

Making Connections for the Health of People and Our World: Teva's 2021 ESG Progress Report

Rise of the Superbugs: 5 Key Questions Answered

Rise of the Superbugs: 5 Key Questions Answered